Statistics

Total Visits

Views
First-line response-adapted treatment with the combination of bendamustine and rituximab in patients with mucosaassociated lymphoid tissue lymphoma (MALT2008-01): A multicentre, single-arm, phase 2 trial39

Select a period of time:

Number of views in the range

Views
First-line response-adapted treatment with the combination of bendamustine and rituximab in patients with mucosaassociated lymphoid tissue lymphoma (MALT2008-01): A multicentre, single-arm, phase 2 trial28

Views

Views
January 20250
February 20253
March 202515
April 20252
May 20250
June 20258
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
Hong Kong6
United States4
United Kingdom2
Spain1
 

Top cities views

Views
Hong Kong6
Buffalo1
Council Bluffs1
Dallas1
Scottsdale1